MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.
Expert Rev Clin Pharmacol. 2013;6(3):271-288. Triptans are highly effective for short-term treatment of acute migraine attacks. They are effective in MA or MO, but are not intended for use in ...
Sumatriptan is one of the most commonly prescribed medications to treat migraine attacks. As the pioneer in the triptan class ...